Viewing Study NCT00350701



Ignite Creation Date: 2024-05-05 @ 4:58 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00350701
Status: COMPLETED
Last Update Posted: 2022-02-10
First Post: 2006-07-10

Brief Title: Effect of Androgel on Type 2 Diabetic Males With Hypogonadism
Sponsor: University at Buffalo
Organization: University at Buffalo

Study Overview

Official Title: Effect of Androgel on Inflammatory Mediators and Oxidative Stress in Type 2 Diabetic Males With Hypogonadism
Status: COMPLETED
Status Verified Date: 2022-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is to study the effect of replacing testosterone on different inflammatory cells in type 2 diabetics with low testosterone levels
Detailed Description: Type 2 diabetes is an atherosclerotic pro-inflammatory and pro-oxidative stress Hypogonadism low testosterone is also associated with increased levels of inflammatory mediators and atherosclerosis

This project is about studying the effect of testosterone replacement on different inflammatory cells in blood and urine It will also compare the dose dependent effect on inflammatory cells This also involves comparing level of inflammation in hypogonadic diabetic males treated with testosterone with those not treated with any replacement therapy

This study involves applying AndroGel for 8 wks and studying effects during this time and thereafter

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None